__NUXT_JSONP__("/drugs/Icotinib_Hydrochloride", (function(a,b,c,d){return {data:[{drug:{slug:a,emaEpar:[],fdaDrugLabel:[],id:a,nciThesaurus:{casRegistry:"1204313-51-8",chebiId:b,chemicalFormula:b,definition:"The hydrochloride salt form of icotinib, an orally available quinazoline-based inhibitor of epidermal growth factor receptor (EGFR), with potential antineoplastic activity. Icotinib selectively inhibits the wild-type and several mutated forms of EGFR tyrosine kinase. This may lead to an inhibition of EGFR-mediated signal transduction and may inhibit cancer cell proliferation. EGFR, a receptor tyrosine kinase, has been upregulated in a variety of cancer cell types.",fdaUniiCode:"JTD32I0J83",identifier:"C99160",preferredName:c,semanticType:"Organic Chemical",subclassOf:["C129825","C2167"],synonyms:["(1,4,7,10)Tetraoxacyclododecino(2,3-g)quinazolin-4-amine, N-(3-ethynylphenyl)-7,8,10,11,13,14-hexahydro-, Hydrochloride (1:1)","BPI-2009H","Conmana","ICOTINIB HYDROCHLORIDE","Icotinib HCl",c]},dir:"\u002Fdrugs",path:"\u002Fdrugs\u002FIcotinib_Hydrochloride",extension:".json",createdAt:d,updatedAt:d}}],fetch:{},mutations:void 0}}("Icotinib_Hydrochloride","","Icotinib Hydrochloride","2021-10-30T13:49:00.463Z")));